The study, recently published in Nature Communications, shows the new technique can also overcome some of the challenges of current testing.
Users answer a series of daily questions about their mood and where they are experiencing pain. In return, the app rewards them in the form of advice or songs, resources intended to increase their motivation.
Across the country, telehealth use has spiked as providers offer virtual patient visits to ensure medical needs are met while minimizing COVID-19 exposure. Regulatory agencies have loosened some restrictions on telehealth during this crisis, and more and more payers have begun to reimburse for it as they would for any other medical service.
In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents.